NCT02702310
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
- Locations
-
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
Clinical trial condition
Explore clinical trials studying Stage III Mycosis Fungoides. Study availability and eligibility vary by location and protocol.
NCT02702310